Skip to content

Exploring Massage Benefits for Arthritis of the Knee

Multisite RCT Investigating the Efficacy of Massage in Osteoarthritis

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01537484
Acronym
EMBARK
Enrollment
222
Registered
2012-02-23
Start date
2012-06-30
Completion date
2015-06-30
Last updated
2017-04-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Osteoarthritis

Keywords

massage, osteoarthritis, light touch, Swedish

Brief summary

The purpose of this study is to verify the efficacy of an 8-week course of manualized Swedish massage for reducing pain and increasing function compared to light-touch bodywork, and usual care, in 222 adults with OA of the knee.

Interventions

PROCEDUREMassage Therapy

Swedish Massage for 1 hour for 8 weeks, Light Touch Bodywork for 1 hours for 8 weeks.

Sponsors

National Center for Complementary and Integrative Health (NCCIH)
CollaboratorNIH
Duke University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
FACTORIAL
Primary purpose
OTHER
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
35 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* 35 years of age or greater. * Written confirmation of OA of the knee as provided by the participant's physician. * Radiographically-established OA of the knee. * Pre-randomization rating within a certain range on the Visual Analog Pain Scale (0 - 100 mm scale). * Receiving care for diagnosed OA of the knee under the care of a board-certified primary care physician, with or without involvement of a board-certified rheumatologist. * Patients with bilateral knee involvement will have the more severely affected knee designated as the study knee. * American College of Rheumatology defined OA of the knee; specifically: a. Knee pain b. Satisfaction of at least three of the following six criteria: i. Age great than 50 years ii. Stiffness \< 30 minutes iii. Crepitus iv. Bony Tenderness v. Bony enlargement vi. No palpable warmth

Exclusion criteria

* Presence of rheumatoid arthritis, fibromyalgia, recurrent or active pseudo gout. * Presence of cancer or other decompensated medical conditions that limit the ability to participate fully in all interventions, assessments, and follow-up visits. * Signs or history of kidney or liver failure. * Presence of asthma requiring the use of corticosteroid treatment. * Use of oral corticosteroids within the past four weeks. * Use of intra-articular knee depo-corticosteroids with the past three months. * Use of intra-articular hyaluronate with the past six months. * Arthroscopic surgery of the knee within the past year. * Significant injury to the knee within the past six months. * Presence of a rash or open wound over the knee. * Unable to satisfy the treatment and follow-up requirements. * Unable to provide written informed consent. * Currently receiving massage therapy on a regular basis (at least twice a month). * Knee replacement of study knee (ok if the knee not being studied has been replaced). * History of participating in the EMBARK Phase I or II studies.

Design outcomes

Primary

MeasureTime frameDescription
Change in Western Ontario and McMaster Universities Osteoarthritis of the Knee and Hip Index (WOMAC)Baseline, 8, 16, 24, 36 and 52 weeks (Baseline, 8, 16, 24, 32, 40 and 48 for Usual Care group)The Index is self-administered and assesses the three dimensions of pain, disability and joint stiffness in knee and hip osteoarthritis through 24 questions. WOMAC 3.1 is available in 65 languages using either a five-point Likert scale or a 100 mm visual analog scale. The WOMAC has been subject to numerous validation studies to assess reliability and responsiveness to change in therapy, including physical forms of therapy

Secondary

MeasureTime frameDescription
Change in Pain: The Visual Analog Scale (VAS)Baseline, 8, 16, 24, 36 and 52 weeks (Baseline, 8, 16, 24, 32, 40 and 48 for Usual Care group)Used to measure pain sensation intensity evoked by nociceptive stimuli. Subjects quickly and easily rate stimuli within the series by indicating level of pain on a 100 mm scale. Pain intensity is represented by the participant drawing a line on the scale indicative of pain experienced (0 = no pain, to 100 = worse pain imaginable). The VAS is anchored at the left by no pain sensation and at the right by the most intense pain sensation imaginable.
Change in Pain: PROMIS Pain Interference QuestionnaireBaseline, 8, 16, 24, 36 and 52 weeks (Baseline, 8, 16, 24, 32, 40 and 48 for Usual Care group)Patient Reported Outcomes Measurement Information System (PROMIS), funded by the National Institutes of Health (NIH), is a system of highly reliable, valid, flexible, precise, and responsive assessment tools that measure patient-reported health status. The Pain Interference Questionnaire has 6 questions answered on an ordinal scale of five gradations.
Change in Joint FlexibilityBaseline, 8, 16, 24, 36 and 52 weeks (Baseline, 8, 16, 24, 32, 40 and 48 for Usual Care group)Joint flexibility is defined as the range of motion (ROM) allowed at the knee. The knee's ROM is measured by the number of degrees from the starting position of a segment to its position at the end of its full range of the movement. This is measured using a double-armed goniometer. A stationary arm holding a protractor is placed parallel with a stationary body segment and a movable arm moves along a moveable body segment. The pin (axis of goniometer) is placed over the joint.
Change in Physical FunctionBaseline, 8, 16, 24, 36 and 52 weeks (Baseline, 8, 16, 24, 32, 40 and 48 for Usual Care group)Measured time in seconds to walk fifty (50) feet (15 m) on a level surface within the clinic facilities.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 25, 2026